← Browse by Condition
Medical Condition

rifampin resistant pulmonary tuberculosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05824871 Phase 3
Recruiting

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Enrollment
450 pts
Location
China
Sponsor
Shanghai Jiatan Pharmatech Co....
View Trial →